scorecardresearch
Business Today
Subscribe
Immersives UPSTART ICC World Cup Corporate Petrol-Diesel Weather BT Bazaar
BT Golf BT 500 Zero Mile Samvad - IIM Nagpur BT-TR GCC Listing
Clear all
Search

COMPANIES

No Data Found

NEWS

No Data Found
Sign in Subscribe
events
Special
  • BT tech today
  • BT 500 wealth creators summit
  • zero mile samvad iim nagpur
News
Markets
Stocks
Astrazeneca Pharma India Ltd

Feedback
Astrazeneca Pharma India Ltd

Astrazeneca Pharma India Ltd (ASTRAZEN) Share Price

  • Sector: Pharmaceuticals (Small Cap)
  • Volume: 726
Dec 15, 2023 10:18 IST-
  • NSE
  • BSE
  • Share
    • Whatsapp
    • Twitter
    • Facebook
₹4,695.45
₹-14.65 (0.07%)
₹4689.8 Low
Today’s Performance
₹4720 High
₹3098 Low
52 Week’s Performance
₹4996.9 High

STOCK ANALYSIS

STOCK PERFORMANCE

  • 1 Day -0.31%
  • 1 Week -2.74%
  • 1 Month 2.13%
  • 3 Months 7.81%
  • 6 Months 28.96%
  • 1 Year 39.01%
  • 3 Years 1.71%
  • 5 Years 27.46%

PEER COMPARISON

STOCK SUMMARY

  • Face Value (₹) 2.00
  • Beta 0.34
  • 52-Week Low (₹) 3,098.00
  • 52-Week High (₹) 4,996.90
  • Price-to-Book (X)* 17.92
  • Dividend Yield (%) 0.34
  • Price-to-Earnings (P/E) (X)* 67.84
  • Earnings Per Share (₹) 69.20
  • Sector Price Earning (X)* 32.73
  • Market Cap (₹ Cr.)* 11,775.25
  • * Vaues as of last close price

COMPETITORS

BT TV

thumb 1:59 Sudeep Shah From SBI Securities Identifies Two Stocks Poised For Strong Upside Movement!
thumb 3:29 Shri Krishna Janmabhoomi Case: High Court Approves Survey Of Shahi Idgah Complex
thumb 2:07 Listen To SMIFS' Sharad Avasthi's Call On DOMS & India Shelter Finance IPOs Ending On Friday
thumb 2:09 Electrifying Delhi's Commute: Delhi's Got More Electric Buses! Hop On Board For A Greener Commute!
thumb 3:59 Derek O'Brien Suspended After Face-off With RS Chairman! MP Charged With "Ignoble Misconduct"
View more

FINANCIAL ANALYSIS

Income Statement (₹ Cr.)
Balance Sheet (₹ Cr.)
Cash Flow (₹ Cr.)
Income Statement (₹ Cr.)
Balance Sheet (₹ Cr.)
Cash Flow (₹ Cr.)

RATIO ANALYSIS

Return on Equity (%)
Return on Assets (%)
Price-to-Earnings (P/E) (X)
Price to Book (x)
Return on Capital Employed (%)
Enterprise Value to EBITDA (X)
Net Profit Margin (%)
Gross Profit Margin (%)
EBITDA Margin (%)
Return on Equity (%)
Return on Assets (%)
Price-to-Earnings (P/E) (X)
Price to Book (x)
Return on Capital Employed (%)
Enterprise Value to EBITDA (X)
Net Profit Margin (%)
Gross Profit Margin (%)
EBITDA Margin (%)

SHAREHOLDING PATTERN

Summary (as on 30 sep 2022)

DEALS

Sep 19, 2022 Sell
ASTRAZEN ,ISHARES INDIA SC MAURITIUS COMPANY
  • Qty 6542
  • Average Price ₹3,152.55
Sep 19, 2022 PURCHASE
ASTRAZEN ,ISHARES MSCI INDIA SMALL-CAP ETF
  • Qty 6542
  • Average Price ₹3,152.55
Sep 19, 2022 Sell
ASTRAZEN ,ISHARES CORE EMERGING MARKETS MAURITIUS CO
  • Qty 74097
  • Average Price ₹3,152.55
Sep 19, 2022 PURCHASE
ASTRAZEN ,ISHARES CORE MSCI EMERGING MARKETS ETF
  • Qty 74097
  • Average Price ₹3,152.55
*Single trade that involves transaction of a minimum quantity of 5 lakh shares or a minimum value of ₹ 10 crore.
Apr 03, 2019 Sell
AstraZeneca Pharma India ,ICICI PRUDENTIAL MUTUAL FUND A/C VOLATILITY ADVANTAGE PLAN
  • Qty 125000
  • Average Price ₹2,000.00
May 30, 2013 Sell
AstraZeneca Pharma India ,CROSSEAS CAPITAL SERVICES PVT. LTD.
  • Qty 128849
  • Average Price ₹845.78
May 30, 2013 PURCHASE
AstraZeneca Pharma India ,CROSSEAS CAPITAL SERVICES PVT. LTD.
  • Qty 131291
  • Average Price ₹844.46
May 30, 2013 Sell
Astrazeneca Phar ,CROSSEAS CAPITAL SERVICES PRIVATE LIMITED
  • Qty 126180
  • Average Price ₹845.63
May 30, 2013 Sell
AstraZeneca Pharma India ,CROSSEAS CAPITAL SERVICES PVT. LTD.
  • Qty 128849
  • Average Price ₹845.78
May 30, 2013 PURCHASE
AstraZeneca Pharma India ,CROSSEAS CAPITAL SERVICES PVT. LTD.
  • Qty 131291
  • Average Price ₹844.46
May 30, 2013 Sell
Astrazeneca Phar ,CROSSEAS CAPITAL SERVICES PRIVATE LIMITED
  • Qty 126180
  • Average Price ₹845.63
*Involves transaction of at least 0.5% of the listed shares of a company.

FAQ’S

What was Astrazeneca Pharma India Ltd share price previously?
Astrazeneca Pharma India Ltd share price was down by -0.07% from the previous closing price of ₹4,710.10.
Who are peers of Astrazeneca Pharma India Ltd?
The peers of Astrazeneca Pharma India Ltd are Zydus Lifesciences Ltd, Cipla Ltd, Lupin Ltd, Dr Reddys Laboratories Ltd, Alkem Laboratories Ltd, Divis Laboratories Ltd, Torrent Pharmaceuticals Ltd, Aurobindo Pharma Ltd, Glaxosmithkline Pharmaceuticals Ltd, Sun Pharmaceuticals Industries Ltd, Biocon Ltd, Ipca Laboratories Ltd, Syngene International Ltd, Gland Pharma Ltd.
Who is/are the promoter/promoters of Astrazeneca Pharma India Ltd?
The promotor/promotors of Astrazeneca Pharma India Ltd are Narayan K Seshadri, Revathy Ashok, Rajesh Marwaha., Weiying Sarah Wang, Ankush Nandra, Shilpa Divekar Nirula, Sanjeev Panchal, Hooi Bien Chuah.
What has been 52-week high of Astrazeneca Pharma India Ltd stocks?
The highest price of Astrazeneca Pharma India Ltd stock is ₹4,996.90 in the last 52-week.
What is the share price of Astrazeneca Pharma India Ltd (ASTRAZEN) today on NSE?
As on Dec 15, 2023, Astrazeneca Pharma India Ltd (ASTRAZEN)’s share price on NSE is Rs 4695.45
What is the market cap of Astrazeneca Pharma India Ltd (ASTRAZEN?)
The current market capitalisation of Astrazeneca Pharma India Ltd (ASTRAZEN) is 11,775.25 crores
What is Astrazeneca Pharma India Ltd Share symbol?
The symbol of Astrazeneca Pharma India Ltd is ASTRAZEN.
What is the PE ratio of Astrazeneca Pharma India Ltd (ASTRAZEN)?
The current PE ratio of Astrazeneca Pharma India Ltd (ASTRAZEN) is 67.84.
What is the PB ratio of Astrazeneca Pharma India Ltd (ASTRAZEN)?
The current PB ratio of Astrazeneca Pharma India Ltd (ASTRAZEN) is 17.92.
Today’s High & Low share prices of Astrazeneca Pharma India Ltd (ASTRAZEN) on NSE?
Today, the share price of Astrazeneca Pharma India Ltd (ASTRAZEN) on NSE touched a high of Rs 4720 and a low of Rs 4689.8
What price did Astrazeneca Pharma India Ltd (ASTRAZEN) shares open on the NSE today?
On NSE, the share price of Astrazeneca Pharma India Ltd (ASTRAZEN) opened at Rs 4719.8
What is the 52-week high of Astrazeneca Pharma India Ltd (ASTRAZEN)?
The 52-week high price of Astrazeneca Pharma India Ltd (ASTRAZEN) is Rs 4996.9
What is the 52-week low of Astrazeneca Pharma India Ltd (ASTRAZEN) ?
The 52-week low price of Astrazeneca Pharma India Ltd (ASTRAZEN) is Rs 3098

ABOUT ASTRAZENECA PHAR

Astrazeneca Pharma India Ltd, incorporated in the year 1979, has its registered office in Blk N1 12th Flr Manyata Embass, Rachenahalli Outer Ring Road, Bangalore, Karnataka, 560045, 91-080-67748000, 91-080-67748557. The main industry in which Astrazeneca Pharma India Ltd operates is Pharmaceuticals - Multinational.

Auditor/Auditors for Astrazeneca Pharma India Ltd is/are Price Waterhouse & Co. In the main management, Narayan K Seshadri is chairman and is the company secretary for Astrazeneca Pharma India Ltd.

  • NKS Narayan K Seshadri Chairman & Independent Directo
  • RA Revathy Ashok Non-Exec. & Independent Dir.
  • RM Rajesh Marwaha. Whole Time Director & CFO
  • WSW Weiying Sarah Wang Non Executive Director
  • AN Ankush Nandra Non Executive Director
  • SDN Shilpa Divekar Nirula Non-Exec. & Independent Dir.
  • SP Sanjeev Panchal Managing Director
  • HBC Hooi Bien Chuah Non Executive Director

Top Stories

Thank you! Your transaction has been completed successfully.
Sorry! Transaction failed. Please try again later.

DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

DISCLAIMER: Any and all content on this website, including the tools/ analysis, is provided to you only for convenience and on an “as-is, as-available” basis without representation and warranties of any kind. The content and any output of such tools/ analysis is for informational purposes only and should not be relied upon or construed as investment advice or guarantee for any specific performance/ returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this website, you agree to the Terms of Service and Privacy Policy.

Advertisement